These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Refractory primary immune thrombocytopenia (ITP): current clinical challenges and therapeutic perspectives. Vianelli N, Auteri G, Buccisano F, Carrai V, Baldacci E, Clissa C, Bartoletti D, Giuffrida G, Magro D, Rivolti E, Esposito D, Podda GM, Palandri F. Ann Hematol; 2022 May 24; 101(5):963-978. PubMed ID: 35201417 [Abstract] [Full Text] [Related]
7. Treatment of immune thrombocytopenic purpura in adults. Bussel J. Semin Hematol; 2006 Jul 24; 43(3 Suppl 5):S3-10; discussion S18-9. PubMed ID: 16815346 [Abstract] [Full Text] [Related]
8. Immune thrombocytopenia. Bussel J, Cooper N, Boccia R, Zaja F, Newland A. Expert Rev Hematol; 2021 Nov 24; 14(11):1013-1025. PubMed ID: 34720027 [Abstract] [Full Text] [Related]
9. [Management of immune thrombocytopenia in France before the era of thrombopoietin receptor agonists]. Michel M, Doz M, Leclerc-Teffahi S, Detournay B, Lévy-Bachelot L. Rev Med Interne; 2012 Jun 24; 33(6):305-10. PubMed ID: 22444115 [Abstract] [Full Text] [Related]
10. Dapsone for primary immune thrombocytopenia in adults and children: an evidence-based review. Rodrigo C, Gooneratne L. J Thromb Haemost; 2013 Nov 24; 11(11):1946-53. PubMed ID: 23927583 [Abstract] [Full Text] [Related]
11. Childhood immune thrombocytopenia: a changing therapeutic landscape. Breakey VR, Blanchette VS. Semin Thromb Hemost; 2011 Oct 24; 37(7):745-55. PubMed ID: 22187397 [Abstract] [Full Text] [Related]
12. [New treatment methods for autoimmune thrombocytopenia]. Koene HR. Ned Tijdschr Geneeskd; 2007 Nov 24; 151(47):2609-14. PubMed ID: 18161261 [Abstract] [Full Text] [Related]
13. Diagnosis and management of immune thrombocytopenia in the era of thrombopoietin mimetics. Liebman HA, Pullarkat V. Hematology Am Soc Hematol Educ Program; 2011 Nov 24; 2011():384-90. PubMed ID: 22160062 [Abstract] [Full Text] [Related]
14. Rituximab for the treatment of acute refractory ITP. Kim SG, Whyte D, Pashankar FD. J Pediatr Hematol Oncol; 2014 Apr 24; 36(3):e149-51. PubMed ID: 23669737 [Abstract] [Full Text] [Related]
15. Update on the management of immune thrombocytopenic purpura in children. Tarantino MD, Bolton-Maggs PH. Curr Opin Hematol; 2007 Sep 24; 14(5):526-34. PubMed ID: 17934363 [Abstract] [Full Text] [Related]
16. New insights and therapeutics for immune-mediated thrombocytopenia. Metjian A, Abrams CS. Expert Rev Cardiovasc Ther; 2008 Jan 24; 6(1):71-84. PubMed ID: 18095908 [Abstract] [Full Text] [Related]
17. Rituximab efficacy in the treatment of children with chronic immune thrombocytopenic purpura. Ansari Sh, Rostami T, Yousefian S, Kiumarsi A, Miri-Aliabad G, Ramim T. Pediatr Hematol Oncol; 2014 Sep 24; 31(6):555-62. PubMed ID: 25007304 [Abstract] [Full Text] [Related]
18. Current therapies in primary immune thrombocytopenia. Pels SG. Semin Thromb Hemost; 2011 Sep 24; 37(6):621-30. PubMed ID: 22102265 [Abstract] [Full Text] [Related]
19. Evaluation of children with chronic immune thrombocytopenic purpura and Evans syndrome treated with rituximab. Gokcebay DG, Tavil B, Fettah A, Yarali N, Azik FM, Tunc B. Clin Appl Thromb Hemost; 2013 Sep 24; 19(6):663-7. PubMed ID: 22815318 [Abstract] [Full Text] [Related]